查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018377

血液製品市場規模、佔有率和趨勢分析報告：按產品、抗血栓和抗凝血劑、應用、地區和細分市場預測（2026-2033 年）

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), By Antithrombotic And Anticoagulants, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

血液製品市場概況

2025年全球血液製品市場規模估計為535.6億美元，預計2033年將達到918.8億美元。

預計從 2026 年到 2033 年，市場將以 7.1% 的複合年成長率成長。市場成長的主要促進因素是血液相關疾病發生率的增加、輸血數量的增加以及捐血數量的增加。

此外，血液及其成分在各種外科手術中的廣泛應用、意外事故數量的增加以及捐血的上升，預計也將推動研究期間市場成長。例如，根據美國紅十字會統計，美國每年約有680萬人捐血，採集的紅血球和全血總量約1,360萬單位。

貧血、血友病、白血病和血小板減少性疾病血液相關疾病的日益普遍是全球血液製品市場成長的主要驅動力。根據世界衛生組織（WHO）估計，全球約有16億人患有貧血，推動了對紅血球濃縮液和鐵補充劑的需求。同樣，全球約有40萬人患有血友病，需要定期使用血漿衍生產品，例如凝血因子。此外，根據健康指標與評估研究所（IHME）發布的報告，2021年的全球數據顯示，31.2%的女性患有貧血，而男性僅為17.5%，而且女性貧血的盛行率逐年上升。同樣，異常的血液常規檢查（CBC）檢查結果通常提示潛在感染疾病，因此患者對診斷的需求持續存在。

2025年12月4日，Parse Biosciences宣布推出Evercode全血固定液，該產品可在採集後立即穩定全血樣本，用於單細胞RNA定序應用。本產品簡化了檢體處理流程，無需在採集現場即時分離或對周邊血單核細胞（PBMC）進行特殊處理。這項創新使得血液採集工作流程更加分散和靈活，從而推動了血液檢體領域的創新，尤其是在基因組研究和轉化診斷方面。

輸血在治療多種疾病中至關重要，包括貧血、創傷、手術和癌症。例如，對於白血病患者而言，輸血對於控制病情和緩解症狀至關重要，因為患者自身造血能力受損。此外，慢性病盛行率的上升和醫療技術的進步也進一步推動了血液產品需求的成長。

此外，預計在研究期間，與血液生產方法相關的研發活動的活性化將推動市場成長。例如，2025年12月，詹謝普爾當局在收到研究報告後，命令MGM醫學院血庫引進用於血液篩檢的ELISA試劑盒。這項指令重申了血庫標準化傳染病篩檢方案對於確保輸血安全的重要性。雖然這並非商業產品發布，但此事件凸顯了強力的法律規範對血液製品和篩檢市場的影響，從而推動了對檢驗的血液檢測套組和以合規為導向的檢查室運營的需求。此外，全球新血庫中心的開設也可能帶來巨大的市場機會。例如，2023年3月，肯亞衛生署設立了衛星血庫中心，以改善該地區獲得高品質、安全輸血服務的途徑。

此外，血液採集和儲存技術的創新，包括血漿分離術，提高了高效採集特定血液成分（如血漿和血小板）的能力。這為血漿衍生療法等先進製劑的供應鏈提供了支持。此外，新技術的引入，以及血漿在製藥行業的日益普及，預計將在預測期內進一步推動市場成長。例如，2021年4月，EryPharm公司推出了用於大規模生產培養紅血球的醫療設備，為輸血創造了新的血液來源。世界各國政府正致力於透過實施報銷政策（例如為捐血提供經濟獎勵）來增加捐血量。例如，2021年9月，美國紅十字會發起了一項全國性計劃，旨在盡可能招募捐血，以改善鐮狀細胞貧血症患者的健康狀況。預計這一因素也將在未來幾年推動全球市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 血液製品市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 血液製品市場分析工具

第4章：血液製品市場：估算與趨勢分析範例

  • 2025 年和 2033 年的市佔率（樣本）
  • 全球血液製品市場：依產品分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 全血
    • 紅血球
    • 粒細胞
    • 電漿
    • 血小板
  • 血液成分
    • 全血成分
    • 濃縮紅血球
    • 白血球耗竭的紅血球
    • 冷凍血漿
    • 血小板濃縮液
    • 冷凍機配方
  • 血液製品

第5章：血液製品市場：抗血栓和抗凝血藥物的估算與趨勢分析

  • 抗血栓和抗凝血藥物的市場佔有率（2025 年和 2033 年）
  • 全球血液製品市場：抗血栓和抗凝血藥物展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 血小板凝集抑制劑
    • 糖蛋白抑制劑
    • COX抑制劑
    • ADP拮抗劑
    • 其他
  • 線性溶劑
    • 組織型胞漿素原原活化劑
    • 鏈球菌激酶
    • 尿激酶
  • 抗凝血劑
    • 肝素
    • 維生素K拮抗劑
    • 直接凝血酶抑制劑
    • 直接作用的Xa因子抑制劑

第6章：血液製品市場：按應用分類的估算與趨勢分析

  • 按應用領域分類的市場佔有率，2025 年和 2033 年
  • 全球血液製品市場：依應用領域分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 血小板增多症
  • 肺動脈栓塞
  • 腎功能障礙
  • 心絞痛和血管併發症
  • 其他

第7章 血液製品市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • Pfizer, Inc
    • Bristol-Myers Squibb Company
    • Leo Pharma A/S
    • Sanofi
    • Xiamen Hisunny Chemical Co., LTD
    • AstraZeneca plc
    • Baxter International Inc
    • Portola Pharmaceuticals, Inc.
    • GlaxoSmithKline PLC
    • Shandong East Chemical Industry Co.
    • Celgene Corp.
Product Code: 978-1-68038-455-0

Blood Preparation Market Summary

The global blood preparation market size was estimated at USD 53.56 billion in 2025 and is anticipated to reach USD 91.88 billion by 2033, growing at a CAGR of 7.1% from 2026 to 2033. The growing incidence of blood-related disorders, the rising number of transfusion procedures, and the increasing number of donations are the major factors driving the market.

Moreover, extensive usage of blood and its components in several surgical procedures, increasing number of accidents, and growing donations are also expected to fuel the market growth over the study period. For instance, according to the American National Red Cross, in the U.S., approximately 6.8 million people donate blood, and about 13.6 million units of red blood cells and whole blood are collected annually in the U.S.

The increasing prevalence of blood-related disorders, such as anemia, hemophilia, leukemia, and thrombocytopenia, is a primary driver for the growth of the global blood preparation market. According to the World Health Organization (WHO), it is estimated that anemia affects nearly 1.6 billion people globally, increasing the demand for red blood cell concentrates and iron supplements. Similarly, hemophilia affects approximately 400,000 people worldwide, requiring regular access to plasma-derived products such as clotting factors. In addition, according to a report published by the Institute for Health Metrics and Evaluation (IHME), globally in 2021, 31.2% of women had anemia compared with 17,5% of men, keeping anemia prevalence in women rising over the years. Similarly, abnormal Complete Blood Count (CBC) test results often indicate underlying infections, thereby creating a consistent demand for diagnosis among patient.

On 4 December 2025, Parse Biosciences announced the launch of Evercode Whole Blood Fixation, a solution designed to stabilize whole blood samples immediately after collection for single-cell RNA sequencing applications. The product enables simplified sample handling by eliminating the need for immediate peripheral blood mononuclear cell (PBMC) isolation and specialized processing at collection sites. This development strengthens innovation within the blood sample preparation segment, particularly for genomics research and translational diagnostics, by enabling decentralized and more flexible blood collection workflows.

Transfusions are essential in the treatment of numerous conditions such as anemia, trauma, surgical procedures, and cancer treatments. For instance, in leukemia patients the body's factory that makes blood damaged, hence transfusion is essential to manage the disease and its symptoms. Moreover, the rising prevalence of chronic diseases and advancements in healthcare technologies have further contributed to the growing demand for products.

In addition, increasing research and development activities on preparation methods is anticipated to propel the market growth during the review period. For instance, in December 2025, authorities in Jamshedpur ordered MGM Medical College's blood bank to implement ELISA kits for blood screening following the submission of a probe report. The directive reinforces the importance of standardized infectious disease screening protocols in blood banks to ensure transfusion safety. Although not a commercial product launch, the incident highlights the strong regulatory oversight influencing the blood preparation and screening market, driving demand for validated blood testing kits and compliance-focused laboratory practices. Furthermore, launch of new blood bank centers across the globe are likely to offer ample opportunities for the market. For instance, in March 2023, Kenya's Ministry of Health, introduced a satellite blood bank center for improving access to quality and safe transfusion services in the region.

Furthermore, innovations in blood collection and storage technology, including apheresis, have enhanced the ability to efficiently collect specific blood components such as plasma and platelets. This supports the supply chain for advanced preparations such as plasma-derived therapies. In addition, introduction of novel technologies along with the increasing usage of plasma in the pharmaceutical industry is further projected to contribute to market growth over the forecast period. For instance, in April 2021, EryPharm introduced a medical device to manufacture cultured red blood cells in large quantities and create new blood sources for transfusions. Various governments across the globe are focusing on increasing the number of donations by applying reimbursement policies, such as monetary incentives for donors. For instance, in September 2021, The American Red Cross introduced a national initiative to reach a maximum number of donors to improve health outcomes in patients with sickle cell disease. This factor is also expected to augment the growth of the global market over the next few years.

Global Blood Preparation Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood preparation market report based on product, antithrombotic & anticoagulants, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
    • Cryoprecipitate
  • Blood Derivatives
  • Antithrombotic and Anticoagulants Outlook (Revenue, USD Million, 2021 - 2033)
  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • COX Inhibitors
    • ADP Antagonists
    • Others
  • Fibrinolytics
    • Tissue Plasminogen Activator (tPA)
    • Streptokinase
    • Urokinase
  • Anticoagulants
    • Heparins
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWH)
    • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Anti-thrombotic & Anticoagulants
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Anti-thrombotic & Anticoagulants Outlook
    • 2.2.3. Application Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Preparation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing incidence of blood-related disorders
      • 3.2.1.2. Rising number of transfusion procedures, and increasing donations
      • 3.2.1.3. Increasing research and development activities on preparation methods
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of Transfusion-Related Complication
      • 3.2.2.2. Limited Awareness and Accessibility
  • 3.3. Blood Preparation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Blood Preparation Market: Sample Estimates & Trend Analysis

  • 4.1. Sample Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Blood Preparation Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Whole Blood
    • 4.5.1. Whole Blood Market, 2021 - 2033 (USD Million)
    • 4.5.2. Red Cells
      • 4.5.2.1. Red Cells Market, 2021 - 2033 (USD Million)
    • 4.5.3. Granulocytes
      • 4.5.3.1. Granulocytes Market, 2021 - 2033 (USD Million)
    • 4.5.4. Plasma
      • 4.5.4.1. Plasma Market, 2021 - 2033 (USD Million)
    • 4.5.5. Platelets
      • 4.5.5.1. Platelets Market, 2021 - 2033 (USD Million)
  • 4.6. Blood Components
    • 4.6.1. Whole Blood Components
      • 4.6.1.1. Whole Blood Components Market, 2021 - 2033 (USD Million)
    • 4.6.2. Packed Red Cells
      • 4.6.2.1. Packed Red Cells Market, 2021 - 2033 (USD Million)
    • 4.6.3. Leukocyte Reduced Red Blood Cells
      • 4.6.3.1. Leukocyte Reduced Red Blood Cells Market, 2021 - 2033 (USD Million)
    • 4.6.4. Frozen Plasma
      • 4.6.4.1. Frozen Plasma Market, 2021 - 2033 (USD Million)
    • 4.6.5. Platelet Concentrate
      • 4.6.5.1. Whole Blood Components Market, 2021 - 2033 (USD Million)
    • 4.6.6. Cryoprecipitate
      • 4.6.6.1. Cryoprecipitate Market, 2021 - 2033 (USD Million)
  • 4.7. Blood Derivatives
    • 4.7.1. Blood Derivatives Market, 2021 - 2033 (USD Million)

Chapter 5. Blood Preparation Market: Anti-Thrombotic and Anticoagulants Estimates & Trend Analysis

  • 5.1. Anti-Thrombotic and Anticoagulants Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Blood Preparation Market by Anti-Thrombotic and Anticoagulants Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Platelet Aggregation Inhibitors
    • 5.5.1. Platelets Aggregation Inhibitors Market, 2021 - 2033 (USD Million)
    • 5.5.2. Glycoprotein Inhibitors
      • 5.5.2.1. Glycoprotein Inhibitors Market, 2021 - 2033 (USD Million)
    • 5.5.3. COX Inhibitors
      • 5.5.3.1. COX Inhibitors Market, 2021 - 2033 (USD Million)
    • 5.5.4. ADP Antagonist
      • 5.5.4.1. ADP Antagonist Market, 2021 - 2033 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.6. Fibrinolytics
    • 5.6.1. Fibrinolytics Market, 2021 - 2033 (USD Million)
    • 5.6.2. Tissue Plasminogen Activator
      • 5.6.2.1. Others Market, 2021 - 2033 (USD Million)
    • 5.6.3. Streptokinase
      • 5.6.3.1. Streptokinase Market, 2021 - 2033 (USD Million)
    • 5.6.4. Urokinase
      • 5.6.4.1. Urokinase Market, 2021 - 2033 (USD Million)
  • 5.7. Anticoagulants
    • 5.7.1. Anticoagulants Market, 2021 - 2033 (USD Million)
    • 5.7.2. Heparins
      • 5.7.2.1. Heparins Market, 2021 - 2033 (USD Million)
      • 5.7.2.2. Unfractionated heparin
        • 5.7.2.2.1. Unfractionated heparin Market, 2021 - 2033 (USD Million)
      • 5.7.2.3. Low Molecular Weight heparin
        • 5.7.2.3.1. Low Molecular Weight Heparin Market, 2021 - 2033 (USD Million)
      • 5.7.2.4. Ultra-Low Molecular Weight Heparin
        • 5.7.2.4.1. Ultra-Low Molecular Weight Heparin Market, 2021 - 2033 (USD Million)
    • 5.7.3. Vitamin K Antagonist
      • 5.7.3.1. Vitamin K Antagonist Market, 2021 - 2033 (USD Million)
    • 5.7.4. Direct Thrombin Inhibitors
      • 5.7.4.1. Direct Thrombin Inhibitors Market, 2021 - 2033 (USD Million)
    • 5.7.5. Direct factor Xa inhibitors
      • 5.7.5.1. Direct factor Xa Inhibitors Market, 2021 - 2033 (USD Million)

Chapter 6. Blood Preparation Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Blood Preparation Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Thrombocytosis
    • 6.5.1. Thrombocytosis Market, 2021 - 2033 (USD Million)
  • 6.6. Pulmonary Embolism
    • 6.6.1. Pulmonary Embolism Market, 2021 - 2033 (USD Million)
  • 6.7. Renal Impairment
    • 6.7.1. Renal Impairment Market, 2021 - 2033 (USD Million)
  • 6.8. Angina Blood Vessel Complication
    • 6.8.1. Angina Blood Vessel Complication Market, 2021 - 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Other Application Market, 2021 - 2033 (USD Million)

Chapter 7. Blood Preparation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. Pfizer, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bristol-Myers Squibb Company
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Leo Pharma A/S
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sanofi
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Xiamen Hisunny Chemical Co., LTD
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. AstraZeneca plc
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Baxter International Inc
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Portola Pharmaceuticals, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. GlaxoSmithKline PLC
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Shandong East Chemical Industry Co.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Celgene Corp.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 5 Global blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 6 North America blood preparation market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 9 North America blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 10 U.S. blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 12 U.S. blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 13 Canada blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 15 Canada blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Mexico blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 18 Mexico blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Europe blood preparation market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 22 Europe blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Germany blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Germany blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 25 Germany blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 26 UK blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 27 UK blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 28 UK blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 29 France blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 30 France blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 31 France blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 32 Italy blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 34 Italy blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 35 Spain blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Spain blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 37 Spain blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 38 Denmark blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Denmark blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 40 Denmark blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 43 Sweden blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Norway blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 46 Norway blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific blood preparation market, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 51 China blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 52 China blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 53 China blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 54 Japan blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Japan blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 56 Japan blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 57 India blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 58 India blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 59 India blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 60 South Korea blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 61 South Korea blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 62 South Korea blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 63 Australia blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Australia blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 65 Australia blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 67 Thailand blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 68 Thailand blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 69 Latin America blood preparation market, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 72 Latin America blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Brazil blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 74 Brazil blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 75 Brazil blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 76 Argentina blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Argentina blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 78 Argentina blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa blood preparation market, by Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 83 South Africa blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 85 South Africa blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 89 UAE blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 90 UAE blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 91 UAE blood preparation market, by Application, 2021 - 2033 (USD Million)
  • Table 92 Kuwait blood preparation market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait blood preparation market, by Antithrombotic and Anticoagulants, 2021 - 2033 (USD Million)
  • Table 94 Kuwait blood preparation market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Preparation Market Segmentation
  • Fig. 8 Market Snapshot, 2025
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global blood preparation market, Sample Movement Analysis
  • Fig. 16 Global Blood Preparation Market: Product Movement Analysis
  • Fig. 17 Global Blood Preparation Market, for Whole Blood 2021 - 2033 (USD Million)
  • Fig. 18 Global Blood Preparation Market, for Red Cells, 2021 - 2033 (USD Million)
  • Fig. 19 Global Blood Preparation Market, for Granulocytes, 2021 - 2033 (USD Million)
  • Fig. 20 Global Blood Preparation Market, for Plasma 2021 - 2033 (USD Million)
  • Fig. 21 Global Blood Preparation Market, for Platelets, 2021 - 2033 (USD Million)
  • Fig. 22 Global Blood Preparation Market, for Blood Components, 2021 - 2033 (USD Million)
  • Fig. 23 Global Blood Preparation Market, for Whole Blood Components, 2021 - 2033 (USD Million)
  • Fig. 24 Global Blood Preparation Market, for Packed Red Cells, 2021 - 2033 (USD Million)
  • Fig. 25 Global Blood Preparation Market, for Leukocyte Reduced Red Blood Cells, 2021 - 2033 (USD Million)
  • Fig. 26 Global Blood Preparation Market, for Frozen Plasma 2021 - 2033 (USD Million)
  • Fig. 27 Global Blood Preparation Market, for Platelet Concentrate 2021 - 2033 (USD Million)
  • Fig. 28 Global Blood Preparation Market, for Cryoprecipitate 2021 - 2033 (USD Million)
  • Fig. 29 Global Blood Preparation Market, for Blood Derivatives, 2021 - 2033 (USD Million)
  • Fig. 30 Global Blood Preparation Market: Antithrombotic & Anticoagulants Type Movement Analysis
  • Fig. 31 Global Blood Preparation Market, for Platelet Aggregation Inhibitors, 2021 - 2033 (USD Million)
  • Fig. 32 Global Blood Preparation Market, for Glycoprotein Inhibitors, 2021 - 2033 (USD Million)
  • Fig. 33 Global Blood Preparation Market, for COX Inhibitors, 2021 - 2033 (USD Million)
  • Fig. 34 Global Blood Preparation Market, for ADP Antagonists, 2021 - 2033 (USD Million)
  • Fig. 35 Global Blood Preparation Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 36 Global Blood Preparation Market, for Fibrinolytics, 2021 - 2033 (USD Million)
  • Fig. 37 Global Blood Preparation Market, for Tissue Plasminogen Activator (tPA) 2021 - 2033 (USD Million)
  • Fig. 38 Global Blood Preparation Market, for Streptokinase 2021 - 2033 (USD Million)
  • Fig. 39 Global Blood Preparation Market, for Urokinase 2021 - 2033 (USD Million)
  • Fig. 40 Global Blood Preparation Market, for Anticoagulants, 2021 - 2033 (USD Million)
  • Fig. 41 Global Blood Preparation Market, for Heparins, 2021 - 2033 (USD Million)
  • Fig. 42 Global Blood Preparation Market, for Unfractionated Heparin 2021 - 2033 (USD Million)
  • Fig. 43 Global Blood Preparation Market, for Low Molecular Weight Heparin (LMWH) 2021 - 2033 (USD Million)
  • Fig. 44 Global Blood Preparation Market, for Ultra-low Molecular Weight Heparin 2021 - 2033 (USD Million)
  • Fig. 45 Global Blood Preparation Market, for Vitamin K Antagonists, 2021 - 2033 (USD Million)
  • Fig. 46 Global Blood Preparation Market, for Direct Thrombin Inhibitors, 2021 - 2033 (USD Million)
  • Fig. 47 Global Blood Preparation Market, for Direct Factor Xa Inhibitors, 2021 - 2033 (USD Million)
  • Fig. 48 Global Blood Preparation Market, : Application Movement Analysis
  • Fig. 49 Global Blood Preparation Market, for Thrombocytosis, 2021 - 2033 (USD Million)
  • Fig. 50 Global Blood Preparation Market, for Pulmonary Embolism 2021 - 2033 (USD Million)
  • Fig. 51 Global Blood Preparation Market, for Renal Impairment 2021 - 2033 (USD Million)
  • Fig. 52 Global Blood Preparation Market, for Angina Blood Vessel Complications, 2021 - 2033 (USD Million)
  • Fig. 53 Regional Marketplace: Key Takeaways
  • Fig. 54 Regional Outlook, 2025 & 2033
  • Fig. 55 Global Blood Preparation Market, Region Movement Analysis
  • Fig. 56 North America blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 57 U.S. blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 58 Canada blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 59 Mexico blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 60 Europe blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 61 Germany blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 62 UK blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 63 France blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 64 Italy blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 65 Spain blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 66 Denmark blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 67 Sweden blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 68 Norway blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 70 Japan blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 71 China blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 72 India blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 73 Australia blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 77 Brazil blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 79 Middle East and Africa blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 81 Saudi Arabia blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 82 UAE blood preparation market, 2021 - 2033 (USD Million)
  • Fig. 83 Kuwait blood preparation market, 2021 - 2033 (USD Million)